Insulin pump technology fully funded for people with type 1 diabetes
Since October 2024, technology for all people living with type 1 diabetes (T1) has been fully funded. In Waikato, 66 per cent of people with T1 are now using Automated Insulin Delivery (AID), also known as insulin pump therapy.
If you have patients with T1 in your practice who are not currently using an insulin pump, we encourage you to discuss the benefits of AID with them and refer them to the Regional Diabetes Service via BPAC for assessment and support with transitioning. Evidence shows that AID can significantly improve quality of life and glycaemic control, without increasing hypoglycaemia, helping to reduce the risk of long-term diabetes-related complications.
For prescribing support, please refer to the T1 consumables prescriber guide for primary care. If you have any questions, contact Kathy Knight, Waikato Clinical Diabetes Specialist.